Owned and operated by scientists with decades of experience in biomarker-based drug development, clinical trial strategies and patient stratification approaches, Noble Life Sciences provides services including cellular and animal based disease models and a proven biomarker validation platform for early stage drug and diagnostic product development.
Noble Life Sciences enables the development of personalized medicines by providing a range of services including a proven fit-for-purpose biomarker selection and validation process for patient stratification; preclinical drug testing services; cellular- and animal-based disease models; and a best-in-class vivarium.
One of the biggest challenges in preclinical research is procuring high quality animal services to support your drug development mission. With numerous certifications and accreditations and backed by years of experience in animal housing and husbandry, Noble offers our clients the highest quality vivarium services with a responsive and highly flexible approach to your needs.
Noble is led by a team of scientists with deep expertise in early-stage drug development, biomarker discovery and validation, and specialized models for driving drug development. In addition to offering standard services, Noble's professional staff can implement personalized medicine approaches to help guide your research and development programs.